Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (431-440 of 651) with videos related to

Pageof 66
Sort By:
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
Leukemia & Lymphoma|November 8, 2011
Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemiaChristoph Röllig, Christian Brandts, Shabnam Shaid, et al.
The Journal of Biological Chemistry|May 26, 2004
Identification of interaction partners and substrates of the cyclin A1-CDK2 complexSven Diederichs, Nicole Bäumer, Ping Ji, et al.
Molecular and Cellular Biology|March 17, 2004
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cellsCarsten Müller-Tidow, Björn Steffen, Thomas Cauvet, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
S100A2 induces metastasis in non-small cell lung cancerEtmar Bulk, Bülent Sargin, Utz Krug, et al.
Molecular Cell|December 11, 2024
Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signaturesIvan Milenkovic, Sonia Cruciani, Laia Llovera, et al.
Oncoimmunology|October 6, 2018
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myelomaMohamed H S Awwad, Katharina Kriegsmann, Julian Plaumann, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Studies in Health Technology and Informatics|September 1, 2016
Key Data Elements in Myeloid LeukemiaJulian Varghese, Christian Holz, Phillip Neuhaus, et al.
Pageof 66

Showing results (431-440 of 651) with videos related to

Sort By:
Pageof 66
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
Leukemia & Lymphoma|November 8, 2011
Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemiaChristoph Röllig, Christian Brandts, Shabnam Shaid, et al.
The Journal of Biological Chemistry|May 26, 2004
Identification of interaction partners and substrates of the cyclin A1-CDK2 complexSven Diederichs, Nicole Bäumer, Ping Ji, et al.
Molecular and Cellular Biology|March 17, 2004
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cellsCarsten Müller-Tidow, Björn Steffen, Thomas Cauvet, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
S100A2 induces metastasis in non-small cell lung cancerEtmar Bulk, Bülent Sargin, Utz Krug, et al.
Molecular Cell|December 11, 2024
Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signaturesIvan Milenkovic, Sonia Cruciani, Laia Llovera, et al.
Oncoimmunology|October 6, 2018
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myelomaMohamed H S Awwad, Katharina Kriegsmann, Julian Plaumann, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Studies in Health Technology and Informatics|September 1, 2016
Key Data Elements in Myeloid LeukemiaJulian Varghese, Christian Holz, Phillip Neuhaus, et al.
Pageof 66